chevron_leftBack
As of 24 April 2025, AstraZeneca Pharma India Ltd. has a market cap of $2.62B USD, ranking #4491 globally and #306 in India. It ranks #404 in the Healthcare sector, and #76 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$2.62BUSD
223.56B INR
Enterprise Value
$2.56BUSD
218.76B INR
Revenue (TTM)
$189.73MUSD
16.19B INR
EBITDA (TTM)
$23.86MUSD
2.04B INR
Net Income (TTM)
$11.36MUSD
969.7M INR
EBITDA Margin
13%
Profit Margin
6%
PE Ratio
230.5
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Sanjeev Panchal
open_in_new
Employees
940
Founded
1979
Website
astrazeneca.in
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.8% | 5.6% | 5.7% | 29% | 25% | 72% |
Upcoming Earnings
Earnings Date
Thu, May 29
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ASTRAZEN
AstraZeneca Pharma India Ltd
ISIN: INE203A01020
Shares Out.:
Shares Outstanding:
25.0M1
Shares Float:
4.876M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
9.04K INR | |
|
506820
(ASTRAZEN)
AstraZeneca Pharma India Ltd
ISIN: INE203A01020
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
8.75K INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About AstraZeneca Pharma India Ltd.
AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease, renal, and metabolism medicines under the CRESTOR, Forxiga, BRILINTA, Xigduo, and Seloken XL brand names; oncology medicines under the TAGRISSO, CALQUENCE, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
